ARCHIVES

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Hutchinson Center Receives NCI Grant For Immunotherapy Network

October 15, 2010

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

Letter: A Modest Proposal To Abolish FDA

January 26, 1996